|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:activeIngredient
|
gptkb:rVSV-ZEBOV
|
|
gptkbp:age
|
18 years and older
|
|
gptkbp:approvalYear
|
2019
|
|
gptkbp:approvedBy
|
gptkb:European_Union
gptkb:United_States
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
|
|
gptkbp:ATCCode
|
gptkb:J07BX02
|
|
gptkbp:brand
|
gptkb:Ervebo
|
|
gptkbp:contains
|
gptkb:recombinant_vesicular_stomatitis_virus
glycoprotein of Zaire ebolavirus
|
|
gptkbp:developedBy
|
gptkb:Public_Health_Agency_of_Canada
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ervebo
|
|
gptkbp:indication
|
gptkb:Ebola_virus_(Zaire_ebolavirus)_infection
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Merck
|
|
gptkbp:marketedAs
|
gptkb:Merck_Sharp_&_Dohme_Corp.
|
|
gptkbp:pregnancyCategory
|
not recommended
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:storage
|
-80°C to -60°C
|
|
gptkbp:synonym
|
gptkb:rVSVΔG-ZEBOV-GP
|
|
gptkbp:target
|
gptkb:Ebola_virus_disease
|
|
gptkbp:type
|
live attenuated vaccine
|
|
gptkbp:usedFor
|
prevention of Ebola virus disease
|
|
gptkbp:WHOPrequalified
|
yes
|
|
gptkbp:bfsParent
|
gptkb:vaccine
|
|
gptkbp:bfsLayer
|
4
|